| Financial Year |
March 31 2023 |
| Monetary Funds |
23,209,733,828.29 |
| Held-for-trading Financial Assets |
132,800.00 |
| Notes Receivable |
60,000,000.00 |
| Accounts Receivable |
122,190,424.55 |
| Advances to Suppliers |
1,408,895,759.71 |
| Other Receivables |
333,422,341.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
41,857,754,383.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
932,950,281.88 |
| Total Current Assets |
67,925,079,819.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
590,732,343.52 |
| Investment Properties |
124,424,298.79 |
| Fixed Assetes |
107,478,005,647.40 |
| Under-construction Projects |
6,366,053,561.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
7,393,865,786.51 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
967,914,488.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,953,162.08 |
| Deferred Income Tax Assets |
49,037,892.74 |
| Other Non-Current Assets |
571,642,465.88 |
| Sub-Total of Non-Current Assets |
130,164,563,931.19 |
| Total Assets |
198,089,643,750.55 |
| Short-Term Loans |
40,664,243,443.15 |
| Trading Financial liabilities |
9,876,014.98 |
| Notes Payable |
2,268,466,323.65 |
| Accounts Payable |
22,124,042,601.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,482,470,543.83 |
| Taxes Payable |
45,628,471.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,150,032,292.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,012,932,000.85 |
| Other Current Liabilities |
100,073,629.79 |
| Sub-Total of Current Liabilities |
85,532,975,636.68 |
| Long-term Loans |
9,791,742,984.87 |
| Bonds Payable |
8,994,096,725.40 |
| Long-Term Accounts Payable |
2,208,659,917.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,126,869,104.78 |
| Total Liabilities |
111,659,844,741.46 |
| Paid-In Capital(Or Share Stock) |
5,469,778,740.00 |
| Capital Surplus |
17,757,542,013.46 |
| Surplus Reserve |
1,955,992,514.78 |
| LESS:Treasury Stock |
2,473,832,562.77 |
| Undistributed Profits |
46,589,824,785.61 |
| Minority Stockholder's Interest |
16,123,028,449.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
70,306,770,559.19 |
| Owner's Equity（Stockholder's Equity） |
86,429,799,009.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
198,089,643,750.55 |
